Response Pharmaceuticals Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$4.99M
- Investors
-
7
Response Pharmaceuticals General Information
Description
Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. The company develops treatments for post-prandial triglyceride levels, body weight, and other cardiometabolic risk factors in individuals discontinuing semaglutide or tirzepatide, enabling patients to recover from mental illness and combat weight gain and metabolic dysregulation.
Contact Information
Website
www.responsepharmaceuticals.comCorporate Office
- 1104 West Broad Street
- Suite 1064
- Falls Church, VA 22046
- United States
Corporate Office
- 1104 West Broad Street
- Suite 1064
- Falls Church, VA 22046
- United States
Response Pharmaceuticals Timeline
Response Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 21-Nov-2025 | $4.99M | Completed | Clinical Trials - Phase 2 | ||
| 2. Early Stage VC (Series B1) | 28-Jun-2024 | Completed | Clinical Trials - Phase 2 | |||
| 1. Early Stage VC (Series A) | 02-Dec-2022 | $7.99M | $7.99M | Completed | Clinical Trials - Phase 1 |
Response Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B-1 | ||||||||
| Series A | 8,000,000 | $0.000100 | $1 | $1 | 1x | $1 | 39.2% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Response Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Response Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Response Pharmaceuticals Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Green Park & Golf Ventures | Venture Capital | Minority | ||
| Momentum Biotech | Angel Group | Minority | ||
| Evolution VC Partners | Venture Capital | Minority | ||
| Transhuman Capital | Venture Capital | Minority | ||
| Collage Venture Partners | Venture Capital | Minority |
Response Pharmaceuticals FAQs
-
When was Response Pharmaceuticals founded?
Response Pharmaceuticals was founded in 2021.
-
Where is Response Pharmaceuticals headquartered?
Response Pharmaceuticals is headquartered in Falls Church, VA.
-
What is the size of Response Pharmaceuticals?
Response Pharmaceuticals has 10 total employees.
-
What industry is Response Pharmaceuticals in?
Response Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Response Pharmaceuticals a private or public company?
Response Pharmaceuticals is a Private company.
-
What is the current valuation of Response Pharmaceuticals?
The current valuation of Response Pharmaceuticals is .
-
What is Response Pharmaceuticals’s current revenue?
The current revenue for Response Pharmaceuticals is .
-
How much funding has Response Pharmaceuticals raised over time?
Response Pharmaceuticals has raised $16.9M.
-
Who are Response Pharmaceuticals’s investors?
Green Park & Golf Ventures, Momentum Biotech, Evolution VC Partners, Transhuman Capital, and Collage Venture Partners are 5 of 7 investors who have invested in Response Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
